Methods of inhibiting angiogenesis via increasing in vivo...

Details Methods of inhibiting angiogenesis via increasing in vivo... Methods of inhibiting angiogenesis via increasing in vivo...

2005-09-27

2005-09-27

Carlson, Karen Cochrane (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S300000, C530S350000

Reexamination Certificate

active

06949511

ABSTRACT:
The present invention provides methods of inhibiting angiogenesis by increasing the concentration of kringle region fragments of plasminogen molecules in vivo. The methods of the present invention may be used for the treatment of angiogenesis-dependent diseases such as cancer.

REFERENCES:
patent: 5639725 (1997-06-01), O'Reilly
patent: 5733876 (1998-03-01), O'Reilly
patent: 5776704 (1998-07-01), O'Reilly
patent: 5792845 (1998-08-01), O'Reilly
patent: 5837682 (1998-11-01), Folkman et al.
patent: 5854221 (1998-12-01), Cao et al.
patent: 5861372 (1999-01-01), Folkman et al.
patent: 5885795 (1999-03-01), O'Reilly
patent: 5945403 (1999-08-01), Folkman et al.
patent: 6024688 (2000-02-01), Folkman et al.
patent: J58036391 (1983-03-01), None
patent: WO 91/10424 (1991-07-01), None
patent: WO 93/1671 (1993-09-01), None
patent: WO 95/25543 (1995-09-01), None
patent: WO 95/29242 (1995-11-01), None
Abe, N. et al., “Identification of a Novel Collagen Chain Represented by Extensive Interruptions in the Triple-Helical Region”,Biochem. and Biophy. Resch. Comm.,vol. 196, No. 2, pp. 576-582 (1993).
Algire, G.H. et al., “Vascular reactions of normal and malignant tumors in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants”,J. Natl. Canc. Inst.,vol. 6, pp. 73-85 (1945).
Angiolillo, A.I. et al., “Human interferon-inducible Protein 10 is a potent inhibitor of angiogenesis in vivo”,J. Exp. Med.,vol. 182, pp. 155-162 (1995).
Brem, H. et al., “Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas”,J. Neurosurg.,vol. 74, pp. 441-446 (1991).
Brockway, W. J. et al., “Measurement of the Binding of Antifibrinolytic Amino Acids to Various Plasminogens”,Arch. Biochem. Biophys.,vol. 151, pp. 194-199 (1972).
Browne, M.J. et al., “Expression of Recombinant Human Plasminogen and Aglycoplasminogen in HeLa Cells”,Fibrinolysis,vol. 5, pp. 257-260 (1991).
Cao, Y. et al., “gro-β, α -C-X-C- Chemokine, Is an Angiogenesis Inhibitor That Suppresses the Growth of Lewis Lung Carcinoma in Mice”,J. Exp. Med.,vol. 182, pp. 2069-2077 (1995).
Chen, C. et al., “A Strategy to Discover Circulating Angiogenesis Inhibitors Generated by Human Tumors”,Canc Resch.,vol. 55, pp. 4230-4233 (1995).
Church, W.R. et al., “A Kringle-Specific Monoclonal Antibody”, Hybridoma, vol. 13, No. 5, pp. 423-429, Oct. 1994.
Clapp, C. et al., “The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis”,Endocrinology,vol. 133, pp. 1292-1299 (1993).
Cleary, S. Mulkerrin et al., “Purification and Characterization of Tissue Plasminogen Activator Kringle-2Domain Expressed inEscherichia coli”, Biochem.,vol. 28, pp. 1884-1891 (1989).
Dameron, K.M. et al., “Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1”,Science,vol. 265, pp. 1582-1584 (1994).
Folkman, J., “Tumor angiogenesis and tissue factor”,Nature Med.vol. 2, pp. 167-168 (1996).
Folkman, J., “What is the Evidence that Tumors are Angiogenesis Dependent?”,J. Natl Canc Inst.,vol. 82, pp. 4-6 (1990).
Folkman, J., “Angiogenesis in cancer, vascular, rheumatoid and other disease”,Nature Medicine,vol. 1, No. 1, pp. 27-31 (1995).
Folkman, J., “Long-term culture of capillary endothelial cells”,Proc. Natl. Acad. Sci. USA76, pp. 5217-5221 (1979).
Folkman, J. et al., “Induction of angiogenesis during the transition from hyperplasia to neoplasia”,Nature,vol. 339, pp. 58-61 (1989).
Folkman, J. et al. , “Tumor Behavior in Isolated Perfused Organs In Vitro Growth and Metastases of Biopsy Material in Rabbit Thyroid and Canine Intestinal Segment”,Annals of Surgery,vol. 164, No. 3, pp. 491-501 (1996).
Folkman, J., “Angiogenesis and Its Inhibitors”,Important Advances in Oncology,J.B. Lippincott Company, pp. 42-62 (1985).
Folkman, J., “Tumor Angiogenesis Therapeutic Implications”,NE J. of Med.,No. 18, pp. 1182-1186 (1971).
Gavrieli, Y. et al., “Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation”,J. CellBiol.,vol. 119, pp. 493-501 (1992).
Gimbrone, M.A. et al., “Tumor Growth and Neovascularization An Experimental Model using the Rabbit Cornea”,J. Natl. Canc. Inst.,vol. 52, No. 2 pp. 413-427 (1974).
Gimbrone, M.A. et al., “Tumor Dormancy in Vivo by Prevention of Neovascularization”,J. of Experi. Med.,vol. 136, pp. 261-276 (1972).
Good, D.J. et al., “A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin”,Proc. Nat. Acad. Sci. USA,vol. 87, pp. 6624-6628 (1990).
Grant, D.S. et al., “Scatter factor induces blood vessel formation in vivo”,Proc. Natl. Acad. Sci. USA,vol. 99, pp. 1937-1941 (1993).
Grant, D.S. et al., “Two different Iaminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro”,Cell,vol. 58, pp. 933-943 (1989).
Gross, J.L. et al., “Modulation of Solid Tumor Growth in vivo by bFGF”,Proc. Amer. Assoc. Canc. Resh,vol. 31, p. 79 (1990) [Abstract Only].
Gross, J.L. et al., “Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro.”,Proc. Natl. Acad. Sci. USA,vol. 80, pp. 2623-2627 (1983).
Gunzler, W.A. et al., “The Primary Structure of High Molecular Mass Urokinase from Human Urine”,Hoppe-Seyler's Z. Physiol. Chem.,vol. 363, pp. 1155-1165 (1982).
Gupta, S.K. et al., “A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4”,Proc. Natl. Acad. Sci. USA,vol. 92, pp. 7779-7803 (1995).
Holmgren, L. et al., “Dormancy of micrometastases Balanced proliferation and apoptosis in the presence of angiogenesis suppression”,Nature Medicine,vol. 1, No. 2, pp. 149-153 (1995).
Homandberg, G.A. et al., “Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth”,Am. J. Path.,vol. 120, pp. 327-332 (1985).
Hori, A. et al., “Suppression of Solid tumor Growth by Immunoneutralizing Monoclonal Antibody against Human Basic Fibroblast Growth Factor”,Canc. Resch.,vol. 51, pp. 6180-6184 (1991).
Ingber, D. et al., “Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth”,Nature,vol. 348, pp. 555-557 (1990).
Johansson, J. et al., “Surfactant Protein B: Disulfide Bridges, Structural Properties, and Kringle Similarities”,Biochem.,vol. 30, pp. 6917-6921 (1991).
Kandel, J. et al., “Neovascularization is Associated with a Switch to the Export of bFGF in the Multistep Development of Fibrosarcoma”,Cell,vol. 66, pp. 1095-1104 (1991).
Kim, K. J. et al., “Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo”,Nature,vol. 362, pp. 841-844 (1993).
Kivirikko, S. et al., “Primary Structure of the α1 Chain of Human Type XV Collagen and Exon-Intron Organization in the 3′ Region of the Corresponding Gene”,J. Bio. Chem.,vol. 269, No. 7, pp. 4773-4779 (1994).
Knighton, D. et al., “Avascular and Vascular Phases of Tumor Growth in the Chick Embryo”,Br. J. Cancer,vol. 35, pp. 347-356 (1977).
Lien, W. M. et al., “The blood supply of experimental liver metastases. II. A Microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber”,Surgery,vol. 68, No. 2, pp. 334-340 (1970).
Lerch et al., “Localization of Individual Lysine-Binding Regions in Human Plasminogen and Investigations on Their Complex-Forming Properties”,European Journal of Biochemistry,vol. 107, No. 1, pp. 7-13 (1980).
Lokker, N.A. et al., “Mutat

Affiliated with

Also associated with

Rating

Methods of inhibiting angiogenesis via increasing in vivo... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of inhibiting angiogenesis via increasing in vivo..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting angiogenesis via increasing in vivo... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3394527